
### [MONDO:0020265](http://purl.obolibrary.org/obo/MONDO_0020265)
**Label:** mitochondrial disease with eye involvement

**Subclasses:** [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859) (Leigh disease), [MONDO:0020478](http://purl.obolibrary.org/obo/MONDO_0020478) (Leber plus disease), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0010788](http://purl.obolibrary.org/obo/MONDO_0010788) (Leber hereditary optic neuropathy), 

**Corr. equiv. classes:** [Orphanet:255241](http://www.orpha.net/ORDO/Orphanet_255241), [OMIM:220111](http://purl.obolibrary.org/obo/OMIM_220111), [Orphanet:255210](http://www.orpha.net/ORDO/Orphanet_255210), [OMIM:607426](http://purl.obolibrary.org/obo/OMIM_607426), [Orphanet:255249](http://www.orpha.net/ORDO/Orphanet_255249), [OMIM:500001](http://purl.obolibrary.org/obo/OMIM_500001), [OMIM:308905](http://purl.obolibrary.org/obo/OMIM_308905), [OMIM:616277](http://purl.obolibrary.org/obo/OMIM_616277), [OMIM:614652](http://purl.obolibrary.org/obo/OMIM_614652), [Orphanet:99718](http://www.orpha.net/ORDO/Orphanet_99718), [Orphanet:506](http://www.orpha.net/ORDO/Orphanet_506), [OMIM:535000](http://purl.obolibrary.org/obo/OMIM_535000), [OMIM:165200](http://purl.obolibrary.org/obo/OMIM_165200), [Orphanet:104](http://www.orpha.net/ORDO/Orphanet_104), [OMIM:256000](http://purl.obolibrary.org/obo/OMIM_256000), 

**Class expressions from DL-Learner:**

- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 46.67%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 44.96%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 41.11%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.40%
- Thing 39.38%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 39.38%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 39.15%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 39.15%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 38.33%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 38.33%
- [HP:0000572](http://purl.obolibrary.org/obo/HP_0000572) (Visual loss) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 38.33%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 36.90%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 36.85%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 34.90%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 34.35%


